Новая активная элиминационно-ирригационная интраназальная терапия как патогенетически обоснованный метод профилактики и лечения рецидивирующего и хронического риносинусита

10—30% of human population suffer from sinusltis/rhinosinusltis, 5—15% of the adults and 5% of children have chronic forms. Biofilms play an important role in pathogenesis, they complicate the treatment, especially in patients with recurrent and chronic rhinosinusitis. The new active elimination-irrigation intranasal therapy with Aqualor® Active Soft product containing a carbonated isotonic solution of sterile sea water (0,9% NaCl concentration; 0,4% CO 2 concentration) ensures destruction of biofilms and significantly reduces microbial load; thus, the authors advise to use it in the treatment of patients with rhinosinusitis, especially with relapsing and chronic course.